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Objective: We sought to determine risk factors for deep and superficial chest wound
infections after coronary artery bypass graft surgery to develop predictive models.
Methods: We retrospectively analyzed data collected on 1980 consecutive patients
undergoing coronary artery bypass surgery at our institution between January 1,
1996, and June 30, 1999, by using the Society of Thoracic Surgery database.
Independent risk factors for surgical-site infection were identified with multivariate
logistic regression.
Results: There were 37 (1.9%) deep chest and 46 (2.3%) superficial chest surgical-
site infections. Obese diabetic patients had a 7.7-fold increased risk of deep chest
infections after controlling for intra-aortic balloon pump use (odds ratio, 3.1) and
postoperative transfusion (odds ratio, 2.3). Independent risk factors for superficial
surgical-site infections included obesity (odds ratio, 3.1), diabetes in persons 65
years of age or older (odds ratio, 2.7), and current smoking (odds ratio, 2.5). Use of
antiplatelet drugs was associated with a lower risk of superficial infections (odds
ratio, 0.4). Predicted operative mortality as a marker of severity of illness was not
clearly predictive of deep or superficial surgical-site infection. Mortality in the year
after the operation was increased in patients with deep chest infections compared
with that seen in uninfected control subjects (8/37 [21.6%] vs 114/1612 [7.1%], P
.004) but not in patients with superficial chest infections (7/47 [15.2%] vs 114/1612
[7.1%], P  .075).
Conclusions: Risk factors for deep and superficial chest surgical-site infections after
coronary artery bypass surgery differ, suggesting different mechanisms of patho-
genesis. Appropriate risk stratification models specific to these important outcomes
must be developed.
Up to 20% of patients undergoing coronary artery bypass graft(CABG) surgery in the United States have hospital-acquired in-fections within 30 days of the operation.1 Surgical-site infections(SSIs) are among the most morbid and costly. Risk factors forCABG chest SSI consistently identified in multiple studies in-clude obesity, diabetes, female sex, perioperative blood transfu-
sions, reexploration for bleeding, aortic crossclamp time, and use of bilateral
internal thoracic artery (ITA) grafts.2-18 Advanced age, chronic obstructive pulmo-
nary disease, active smoking, connective tissue disease, reoperation, nasal carriage
of Staphylococcus aureus, operative status, postoperative inotropic support, intra-
aortic balloon pump (IABP) use, postoperative renal failure, and high preoperative
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serum glucose levels (200 mg/dL) have been reported as
risk factors in some studies.2,3,5,6,8,9,11,12,19-22
Risk factors for SSI in patients undergoing CABG must
be identified to devise strategies to minimize or eliminate
them. Some success has been achieved in this endeavor.
Rates of mediastinitis were reduced 2-fold by the use of
mechanical clippers rather than razors for hair removal.23
Overall SSI rates in patients undergoing elective clean or
clean-contaminated operations were reduced more than
2-fold when prophylactic antibiotics were administered no
more than 2 hours before incision compared with perioper-
ative administration (0-3 hours after incision).24 Zerr and
associates25 and Furnary and colleagues26 reported a reduc-
tion in the rate of deep chest SSIs in diabetic patients to the
baseline rates observed in their nondiabetic patients by means
of implementation of a strict glucose-control policy.
With the ultimate objective of developing a predictive
risk model for deep and superficial chest SSI, we retrospec-
tively analyzed our experience with these complications
after CABG surgery over a 42-month period by comparing
patients with and without SSIs to control for severity of
illness. Data on all our patients undergoing CABG surgery
were collected according to the guidelines of the Society of
Thoracic Surgeons (STS) national database, which was es-
tablished for the purpose of risk stratification for mortality
after cardiac operations. Thus the variables selected for
inclusion in the database are those related to the primary
outcome of mortality and include a variety of underlying
medical, operative, and postoperative conditions and proc-
esses of care. We sought to determine whether these same
risk factors predict chest SSI in patients with CABG.
Methods
All patients (n  1980) undergoing CABG surgery at Barnes-
Jewish Hospital between January 1, 1996, and June 30, 1999, were
included. Data were collected prospectively. Preoperative demo-
graphics, operative details, and postoperative complications were
derived from our institutional STS database. All superficial and
deep chest SSIs were cross-checked for accuracy by using the
hospital’s ongoing infection-control database, which is maintained
separately from the surgical database by the infection-control
department in accordance with Centers for Disease Control and
Prevention guidelines. Discrepant results were reconciled with the
patient’s medical record. Control subjects were excluded from
the study only if data for variables found to be important in the
multivariate analyses were missing (no infected subjects had miss-
ing information).
Only confirmed superficial and deep chest SSIs meeting the
National Nosocomial Infections Surveillance criteria and occur-
ring within 30 days of the operation were included in the subse-
quent analysis.27 Deep chest SSIs were defined as involving fascial
and muscle layers or organ spaces plus one of the following: (1)
purulent drainage from the deep incision or organ space; (2)
spontaneous dehiscence of the incision or open exploration by the
surgeon in patients with fever (temperature 38°C), localized
pain, or tenderness; (3) abscess or other evidence of deep infection;
or (4) diagnosis of deep incisional infection, osteomyelititis, or
mediastinitis by a surgeon. Superficial SSIs were defined as in-
volving only skin and subcutaneous tissue of the incision, plus one
of the following: (1) purulent drainage from the superficial inci-
sion; (2) microorganisms isolated from a culture of fluid or tissue
from the superficial incision; (3) pain, tenderness, swelling, red-
ness, or heat in a superficial incision deliberately explored by the
surgeon; or (4) diagnosis of superficial incisional infection by the
surgeon (assumed when antibiotic therapy was instituted).
Variables analyzed by means of univariate analysis included
history of diabetes (including method of treatment), chronic ob-
structive pulmonary disease, congestive heart failure (including
severity and previous myocardial infarction), renal failure, hyper-
tension, hypercholesterolemia, peripheral vascular disease, and
cerebrovascular accident (or transient ischemic attack). Baseline
characteristics tested included body mass index (BMI; ie, weight in
kg/[height in m]2), smoking history, previous cardiac surgical and
nonsurgical interventions, length of hospital stay before the oper-
ation, use of inotropic drugs before the operation, number of
diseased vessels, and use of various preoperative medications.
Operative or postoperative variables included the number and type
of blood transfusions received during and after the operation, use
of ITA grafts, reexploration for bleeding, use of IABP, operative
status, aortic crossclamp time, time on bypass, duration of antibi-
otic prophylaxis before incision, and mortality after the operation.
Active surveillance for mortality in the 30 days after the operation
was performed, whereas mortality after 30 days was assessed
actively for patients readmitted to our hospital and by means of
passive surveillance for patients who did not require readmission
(primarily through reporting by physician’s office staff).
Because risk factors for SSI might also be risk factors for other
types of infections, control patients for all the univariate and multi-
variate analyses were restricted to those patients with no identified
infection within 30 days of the operation. Therefore patients with
sepsis, pneumonia, urinary tract infection, or any SSI (chest, radial
artery, leg, and IABP site) were excluded from the control population.
Statistical analyses were performed with SPSS 10.0 software
(SPSS, Inc, Chicago, Ill). Univariate analyses were performed for
all relevant categoric variables by using contingency tables (2 or
Fisher exact tests for variables with small expected cell numbers)
and t tests or the Mann-Whitney U test for continuous variables.
Multivariate analyses were performed by using logistic regression,
in which all variables with a P value of less than .10 in the
univariate analyses or that were thought to be related to infection
from the literature were included in the initial full models. All
2-way interaction factors involving categoric variables that were
deemed relevant were tested in the models after selection of the
independent risk factors (main effects) and were included in the
final models only if they were significant.28 The final models were
judged to be a good fit for the data by using the Hosmer and
Lemeshow goodness-of-fit test.
Results
Prevalence of Deep and Superficial SSIs and
Univariate Analyses
During the 42-month study interval, 1980 patients under-
went CABG surgery (isolated or in combination with an-
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other cardiac procedure). There were 37 (1.9%) confirmed
deep chest and 46 (2.3%) confirmed superficial chest SSIs.
Selected presurgical patient characteristics are shown in
Table 1. The ages of patients with deep or superficial chest
SSIs were not significantly different from those of patients
without a postsurgical infection (Tables 1 and 2). In con-
trast, the mean BMI was significantly higher in patients with
deep and superficial chest SSIs (Table 2) than in control
TABLE 1. Baseline characteristics of patients who underwent CABG surgery from January 1996 through June 1999
Characteristic
No. (%) of patients
with no infection
(n  1612)
No. (%) of patients with
deep chest infection
(n  37)
No. (%) of patients with
superficial chest infection
(n  46)
Diabetes (total) 563 (34.9) 24 (64.9) 21 (45.7)
Oral therapy 243 (15.2) 11 (29.7) 10 (21.7)
Insulin therapy 236 (14.8) 11 (29.7) 10 (21.7)
Female sex 525 (32.6) 20 (54.1) 21 (45.7)
Race-ethnicity
White 1409 (87.4) 28 (75.7) 39 (84.8)
African American 180 (11.2) 9 (24.3) 6 (13.0)
Other 22 (1.4) 0 1 (2.2)
Surgical data
CABG only 1344 (83.4) 32 (86.5) 38 (82.6)
CABG  valve 168 (10.4) 4 (10.8) 5 (10.9)
CABG  other* 77 (4.8) 1 (2.7) 2 (4.3)
CABG  valve  other 23 (1.4) 1 (2.2)
Previous CABG surgery 140 (8.7) 2 (5.4) 5 (10.9)
Age (y)
60 493 (30.6) 11 (29.7) 20 (43.5)
60-69 520 (32.3) 8 (21.6) 13 (28.3)
70-79 470 (29.2) 14 (37.8) 8 (17.4)
80 129 (8.0) 4 (10.8) 5 (10.9)
Obesity: BMI
30-35 318 (19.7) 16 (43.2) 13 (28.3)
35-40 128 (7.9) 3 (8.1) 7 (15.2)
40 47 (2.9) 4 (10.8) 7 (15.2)
Smoked cigarettes
Ever 1090 (67.6) 22 (59.5) 36 (78.3)
Current smoker 293 (18.2) 4 (10.8) 16 (34.8)
Preexisting comorbidities (other
than diabetes and obesity)
0 328 (20.4) 4 (10.8) 6 (13.3)
1 732 (45.6) 15 (40.5) 20 (44.4)
2 363 (22.6) 13 (35.1) 14 (31.1)
3 182 (11.4) 5 (13.5) 5 (11.1)
Severe congestive heart failure
(NYHA class III or IV)
406 (25.2) 11 (29.7) 14 (30.4)
No. of diseased vessels
None: left main only 39 (2.4) 0 2 (4.3)
Single 216 (13.4) 3 (8.1) 4 (8.7)
Double 441 (27.4) 11 (29.7) 14 (30.4)
Triple 914 (56.7) 23 (62.2) 26 (56.5)
Operative status
Emergency 101 (6.3) 3 (8.1) 1 (2.2)
Urgent 197 (12.2) 6 (16.2) 3 (6.5)
No. of ITA grafts used
0 255 (15.8) 5 (13.5) 6 (13.0)
1 1322 (82.2) 29 (78.4) 37 (80.4)
2 32 (2.0) 3 (8.1) 3 (6.5)
Reoperation for bleeding
Yes 85 (5.3) 2 (5.4) 4 (8.7)
No 1527 (94.7) 35 (94.6) 42 (91.3)
NYHA, New York Heart Association.
*Other category includes any additional cardiac procedure performed at the same time as the CABG surgery.
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subjects. There was a trend toward increasing numbers of
comorbidities (other than diabetes and obesity, which were
examined separately) in patients with deep chest SSIs (P 
.079, 2 test for linear trend) but not in patients with
superficial chest SSIs (P  .269).
Mortality in the first year after the operation was signif-
icantly higher in patients with deep chest SSIs than in
control subjects (8/37 [21.6%] vs 114/1612 [7.1%]; odds
ratio [OR], 3.63; 95% confidence interval [CI], 1.62-8.11;
P  .004), although there was no difference in mortality
within 30 days (P  .438). Five of the 8 patients with deep
chest SSIs who died within a year of their operation also had
sepsis in the month after the operation. Patients with super-
ficial chest SSIs were more likely to die in the first year after
the operation than control patients with no infections, al-
though this was only marginally significant (7/46 [15.2%]
vs 114/1612; OR, 2.36; 95% CI, 1.03-5.39; P  .075).
Three of the 7 patients with superficial chest SSIs who died
within a year of the operation also were septic postopera-
tively. Patients with a harvest-site infection in the month
after the operation were more likely to have a superficial
chest SSI diagnosed than patients without harvest-site in-
fection (6 [7.0%] patients with both a superficial chest SSI
and harvest-site infection of 86 total with harvest-site infec-
tion compared with 37 [2.1%] patients with superficial chest
SSI of 1791 without harvest-site infection; P  .012, Fisher
exact test). In contrast, there was no association between
harvest-site infection and deep chest SSI (1/86 [1.2%] vs
32/1791 [1.8%], P  1.00).
The microbiology of deep and superficial chest SSI was
very similar, although less than one half of the patients with
superficial chest SSIs had wound cultures collected. Staph-
TABLE 2. Univariate analysis of categoric risk factors for deep and superficial chest infections after CABG surgery
Variable
Deep chest infections Superficial chest infections
OR (95% CI) P value OR (95% CI) P value
Age 65 y 1.19 (0.61-2.31) .613 0.47 (0.26-0.87) .014
Female sex 2.44 (1.27-4.69) .006 1.74 (0.97-3.14) .063
Race (nonwhite) 2.24 (1.04-4.82) .044 1.25 (0.55-2.84) .590
BMI 25-30 1.18 (0.39-3.53) .774 5.55 (1.28-24.14) .022
BMI 30-35 4.45 (1.61-12.27) .004 9.03 (2.03-40.31) .004
BMI 35-40 2.07 (0.49-8.79) .323 12.09 (2.48-58.89) .002
BMI 40 7.52 (1.95-28.98) .003 32.91 (6.65-163.01) .001
BMI 30 3.73 (1.90-7.31) .001 3.23 (1.78-5.86) .001
Current smoker of cigarettes 0.54 (0.19-1.54) .244 2.39 (1.28-4.43) .005
Diabetes (all forms of control) 3.42 (1.73-6.77) .001 1.56 (0.86-2.81) .138
Diabetes
Oral control 3.63 (1.61-8.20) .002 1.72 (0.81-3.62) .157
Insulin control 3.74 (1.65-8.44) .002 1.77 (0.84-3.73) .136
Hypercholesterolemia 0.96 (0.49-1.88) .909 1.86 (0.94-3.70) .071
2 previous MI 2.49 (1.22-5.11) .010 0.56 (0.20-1.58) .267
Previous TIA 3.24 (1.32-7.95) .019 0.37 (0.05-2.73) .513
Antiplatelet medication before the
operation
1.80 (0.70-4.64) .221 0.44 (0.24-0.80) .006
Previous nonsurgical cardiac
intervention
1.95 (1.00-3.79) .046 1.67 (0.91-3.08) .094
Previous atherectomy-laser therapy 0.97 (0.23-4.08) 1.000 2.54 (1.05-6.14) .046
Previous thrombolysis 1.78 (0.54-5.94) .419 2.47 (0.95-6.42) .070
IABP inserted during or after CABG
surgery
3.97 (1.50-10.55) .014 0.57 (0.08-4.17) 1.000
Intraoperative cryoprecipitate 1.76 (0.23-13.37) .448 4.43 (1.29-15.23) .040
Intraoperative Hespan 2.21 (1.03-4.74) .047 1.23 (0.54-2.79) .617
Transfusion with 4 units of RBCs
postoperatively
2.55 (1.27-5.15) .007 1.67 (0.84-3.34) .140
Transfusion with 5 units of RBCs
postoperatively
3.11 (1.44-6.71) .007 2.35 (1.12-4.97) .037
Transfusion with 6 units of RBCs
postoperatively
4.57 (2.10-9.93) .001 2.13 (0.88-5.14) .123
Transfusion with 2 units of
platelets postoperatively
4.81 (2.21-10.46) .001 1.04 (0.32-3.42) .763
Transfusion with 3 units of
platelets postoperatively
7.29 (3.06-17.39) .001 2.18 (0.65-7.26) .180
MI, Myocardial infarction; TIA, transient ischemic attack.
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ylococcus aureus was isolated from 54% of patients with
deep chest SSIs (18/33 patients) and from 41% of patients
with superficial chest SSIs (9/22 patients). Gram-negative
bacilli were isolated from approximately one fourth of pa-
tients (8/33 patients with deep SSIs and 5/22 patients with
superficial chest SSIs), whereas coagulase-negative staphy-
lococci were isolated slightly more frequently from patients
with superficial than those with deep chest SSIs (6/22 vs
4/33 patients).
Results of the univariate analyses for categoric risk fac-
tors found to be significantly associated with deep or super-
ficial chest SSIs are shown in Table 2, and the results for
continuous variables are shown in Table 3. After correction
for testing multiple variables (Bonferroni correction), only
obesity (BMI 30), diabetes, and transfusion of 6 or more
units of packed red blood cells (pRBCs) or 2 or more units
of platelets postoperatively were significantly associated
with deep chest SSI. A dose-response relationship between
deep chest infection and the number of units of pRBCs or
platelets is evident (Table 2). Obesity was also significantly
associated with superficial chest SSI (Tables 2 and 3). A
dose-response relationship was apparent between increasing
categories of BMI and superficial chest SSI (2 test for
trend  27.303, P  .001, Table 2). A significant dose-
response relationship increasing categories of BMI and deep
chest SSI also existed, although the increase in ORs was not
as striking as that seen for superficial chest SSI (2 test for
trend  13.394, P  .001, Table 2).
Predicted Risk of Mortality and Prevalence of Deep
and Superficial SSI
Interestingly, almost no other variables representing under-
lying severity of illness other than diabetes and obesity were
significantly associated with deep or superficial chest SSI by
means of univariate analysis. Rates of infection were com-
pared with the predicted risk of mortality computed with the
STS software to confirm this.29 The rates of superficial chest
SSI showed no correlation with the predicted risk of mor-
tality (Figure 1), irrespective of whether the predicted risk
categories were split into quartiles, quintiles, or traditional
risk groups (Figure 1). The correlation of deep chest SSI
with predicted risk of mortality was dependent on the way
in which the predicted risk of mortality was categorized. If
predicted risk was categorized by quintiles or more tradi-
tional risk groups (Figure 1), there was a significant trend
toward increasing risk of deep chest SSI with increased
predicted mortality (P .035 for quintiles and P .049 for
grouping shown in Figure 1, 2 test for trend). If, however,
predicted risk was categorized as quartiles, the trend was no
longer statistically significant (P  .129, 2 test for trend).
In contrast, significant linear trends of increasing risk of SSI
with increasing predicted risk of mortality were observed
for all the systemic infections recorded in the STS database,
no matter how predicted risk was categorized.30
Predictors of Deep SSI From the Multivariate
Analyses
The results of the multivariate analyses to identify independ-
ent risk factors associated with deep chest SSI are shown in
Table 4. Obesity, diabetes, transfusion of 4 or more units of
pRBCs postoperatively, and IABP insertion during or after
the operation were all independent risk factors for deep
chest SSI. Additional multivariate models were created to
assess interactions between variables. In Table 5 the interaction
of obesity and diabetes was compared for deep and superficial
infection after controlling for respective independent risk fac-
TABLE 3. Univariate analysis of continuous variables as risk factors for deep and superficial chest infections after CABG
surgery
Variable
Patients with deep
chest SSIs
Patients with superficial
chest SSIs
Control subjects with
no postoperative
infection
P value for
deep chest
SSIs*
P value for
superficial
chest SSIs*
Age (y) 68 (56-76) 62 (55-72) 66 (57-73) .42 .128
BMI 30.4 (26.6-33.0) 31.7 (26.5-36.3) 27.7 (24.6-30.9) .004 .001
Crossclamp time (min) 73 (55-87) 83 (67-108) 85 (64-109) .015 .920
Time on CPB (min) 126 (101-147) 123 (102-156) 138 (107-168) .075 .226
Lowest core temperature (°C) 32 (30-33) 32 (30-33) 32 (31-33) .715 .377
Duration of antibiotic prophylaxis
before incision (min)
60 (44-80) 65 (52-85) 65 (50-80) .547 .792
Length of procedure (min) 297 (251-354) 311 (284-373) 305 (258-360) .635 .229
Predicted mortality† 2.95 (1.41-6.06) 1.67 (1.09-2.60) 2.02 (1.07-3.92) .082 .415
Chest tube drainage (mL) 575 (425-1100) 655 (398-1019) 771 (509-1160) .282 .198
Days on mechanical ventilation‡ 0.5 (0-0.8) 0.3 (0-0.7) 0.4 (0.2-0.7) .340 .247
Values are given as medians (interquartile ranges) where shown.
*Compared with control patients with no infection during the 30 days after the operation (Mann-Whitney U test).
†Percent predicted mortality calculated with the STS software.
‡After the operation.
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tors. Compared with control subjects, obese diabetic patients
were at greatest risk of both superficial and deep chest SSI.
Obese patients who did not have diabetes were at increased
risk of superficial, but not deep, chest SSI. Nonobese diabetic
patients were not at increased risk for either. Thus the relative
contributions of obesity and diabetes to deep and superficial
SSI appear different, with obesity alone being the primary risk
factor for superficial SSI, whereas for deep SSI, the interaction
of obesity and diabetes confers the greatest risk.
A second multivariate model for deep chest SSI includes
the interaction of postoperative transfusion and obesity (Ta-
ble 6). Among nonobese (BMI  30) patients, deep chest
SSI was more likely to occur in those who received 4 or
more units of pRBCs postoperatively than among those who
did not. This relationship was also apparent if 2 or more
units of platelets was used to define increased rates of
transfusions postoperatively (adjusted OR for deep chest
SSI in nonobese persons who received 2 or more units of
platelets postoperatively  14.2; 95% CI, 4.6-44.0; P 
.001). In contrast, obese individuals were just as likely to
have a deep chest SSI, irrespective of whether they required
transfusions (risk of deep chest SSI in obese patients who
received 4 units of pRBC vs obese patients who received
4 units of pRBCs, P  .552). The lack of a relationship
between increased rates of transfusions and deep chest SSI
in obese individuals was confirmed when transfusion was
defined as receipt of 2 or more units of platelets postoper-
atively (comparison of deep chest SSI in obese patients who
received 2 units of platelets postoperatively and obese
patients receiving 2 units of platelets, P  1.0).
TABLE 4. Multivariate analysis of independent risk factors for deep and superficial chest SSI
Risk factor
Deep chest infections Superficial chest infections
OR (95% CI) P value OR (95% CI) P value
Obesity (BMI 30) 3.36 (1.69-6.67) .001 3.50 (1.92-6.40) .001
Diabetes 2.85 (1.42-5.70) .003
4 units pRBCs postoperatively 2.39 (1.13-5.06) .022
IABP 2.81 (0.98-8.03) .054
Current smoking 2.68 (1.43-5.03) .002
Antiplatelets 0.39 (0.21-0.73) .003
Figure 1. Percentage of patients with deep or superficial chest SSIs according to preoperative predicted mortality.
The percentage of predicted operative mortality, calculated by using the STS software, was categorized into 4
groups: 0% to 1.99%; 2% to 4.99%; 5% to 9.99%; and 10% and greater. The percentage of patients with deep or
superficial chest SSIs was determined within each category of predicted mortality.
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Predictors of Superficial Chest SSI in the Multivariate
Analysis
The multivariate model for superficial chest SSI included
the independent risk factors of obesity, current smoking,
and use of antiplatelet drugs before the operation (Table 4).
In a separate model analyzing the interaction between age
(65 years) and diabetes, increased risk of superficial chest
SSI was limited to younger diabetic patients, with an OR of
2.7 compared with younger patients without diabetes (after
adjusting for other risk factors in the multivariate model,
Table 7). Older diabetic patients were not at increased risk
of superficial chest SSI and were also less likely than
younger diabetic patients to be obese (31% vs 49%; P 
.001, 2 test) and less likely than younger diabetic patients
to be receiving insulin therapy (38% vs 47%; P  .028, 2
test). The increased risk of superficial chest SSI in younger
diabetic patients remained significant after adjusting for
BMI as a continuous variable, suggesting that some factor
other than obesity was responsible for this increased risk in
these patients.
Adjusted Risk of Infection by Surgeon
The results from the multivariate models were then used to
examine the association of individual staff surgeons and
residents with deep and superficial chest SSIs. The percent-
age of patients with superficial chest SSIs varied from 0% to
7.7% for the 17 individual residents with a sufficient num-
ber of procedures to analyze and from 0% to 12.5% for 12
individual attending surgeons. For deep chest SSI, rates
ranged from 0% to 7.1% for individual residents and from
0% to 4.7% for individual attending surgeons. We chose to
analyze the odds of SSI according to resident by creating a
categoric variable, including all individual residents whose
rate of infection was above the mean rate (2.3% for super-
ficial infection and 1.9% for deep chest infection) and using
all individuals at or below the mean as the single reference
category. The ORs for superficial and deep SSIs were cal-
culated for the residents and attending surgeons after ad-
justing for the independent risk factors identified in the
multivariate analyses. Six residents had significantly ele-
vated ORs for superficial chest SSIs by using this criteria
(OR range, 3.8-10.6), and 3 of these same residents had
significantly elevated ORs for deep chest SSIs (ORs of 4.5,
5.7, and 13.5, respectively). The same analyses performed
for attending surgeons identified 3 surgeons with signifi-
cantly elevated ORs for superficial chest SSIs (ORs of 2.2,
3.6, and 9.7, respectively), and one surgeon with a signifi-
cantly elevated OR for deep chest SSIs (OR, 4.6).
During the 42-month time period of this study, one
outbreak of 6 deep chest SSIs associated with one individual
TABLE 5. Risk of superficial and deep chest infections according to coexisting obesity, diabetes, or both*
Category
Deep chest infections Superficial chest infections
No. of infected patients/total in
category (%)
OR†
(95% CI) P value
No. of infected patients/total in
category (%)
OR‡
(95% CI) P value
Neither diabetic nor obese 9/778 (1.2) 1.0 11/780 (1.4) 1.0
Diabetic only 5/351 (1.4) 1.2 (0.4-3.6) .761 8/354 (2.3) 1.7 (0.7-4.4) .238
Obese only 4/277 (1.4) 1.3 (0.4-4.2) .682 14/287 (4.9) 3.9 (1.7-8.8) .001
Both diabetic and obese 19/237 (8.0) 7.7 (3.4-17.4) .001 13/231 (5.6) 4.7 (2.1-10.9) .001
*Compared with 1607 control patients with no infections during the 30-day postoperative period.
†OR for deep chest infections after controlling for 4 or more units of pRBCs transfused postoperatively (adjusted OR, 2.3; 95% CI, 1.1-5.0) and IABP placed
during or after the operation (adjusted OR, 3.1; 95% CI, 1.1-8.9).
‡OR for superficial chest infections after controlling for current smoking (adjusted OR, 2.8; 95% CI, 1.5-5.2) and antiplatelet use before the operation
(adjusted OR, 0.4; 95% CI, 0.2-0.7).
TABLE 6. Postoperative transfusion is a risk factor for deep
chest infections in nonobese patients but not in obese
patients
Obesity
>4 units of pRBCs
postoperatively
No. of infected
patients/total
in category (%)
ORs*
(95% CI) P value
No No 6/939 (0.6) 1.0
No Yes 8/194 (4.1) 5.9 (2.0-17.7) .001
Yes No 19/443 (4.3) 6.0 (2.4-15.3) .001
Yes Yes 4/73 (5.5) 6.5 (1.7-24.2) .006
*ORs adjusted for diabetes (adjusted OR, 2.9; 95% CI, 1.4-5.8) and IABP
placed during or after the operation (adjusted OR, 2.8; 95% CI, 1.0-8.0).
TABLE 7. Younger, but not older, diabetic patients have
increased risk for superficial chest infection
Diabetes Age >65 y
No. of infected
patients/total in
category (%)
ORs*
(95% CI) P value
No No 11/474 (2.3) 1.0
No Yes 14/593 (2.4) 1.4 (0.6-3.3) .413
Yes No 18/273 (6.6) 2.7 (1.2-6.0) .013
Yes Yes 3/312 (1.0) 0.5 (0.1-2.0) .354
*ORs adjusted for obesity (BMI 30; adjusted OR, 3.1; 95% CI, 1.7-5.8),
current smoking (adjusted OR, 2.5; 95% CI, 1.3-4.9), and antiplatelet use
before the operation (adjusted OR, 0.4; 95% CI, 0.2-0.8).
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resident occurred (OR, 13.5). The dates of operation for the
outbreak cases were clustered in a 25-day period, and the
infections were associated with a variety of different bac-
teria (no common organism). After exclusion of the 6 out-
break cases from analysis, the one surgeon identified above
no longer had an elevated OR for deep chest SSI. In con-
trast, no outbreaks of superficial chest SSI were identified,
and the same 3 surgeons had significantly elevated ORs for
superficial chest SSI when the ORs of superficial SSI were
calculated for surgeons after controlling for residents in the
multivariate model.
Discussion
This analysis of risk factors for deep and superficial chest
SSI after CABG surgery indicates that the risk factors for
the 2 types of SSI differ. Increased risk of deep chest SSI
was associated with a combination of obesity and diabetes,
whereas increased risk of superficial chest SSI was associ-
ated primarily with obesity and, to a much lesser extent,
diabetes. The placement of an IABP during or after the
operation and postoperative transfusions were independent
risk factors for deep chest SSI, whereas current smoking
was a risk factor specifically for superficial chest infections,
and antiplatelet use was protective of superficial chest SSI.
The risk of superficial chest SSI was significantly in-
creased in patients with a harvest-site infection in the month
after the operation in comparison with patients without a
harvest-site infection. The majority of the harvest SSIs in
our patient population were superficial infections, and thus
the increased risk of only superficial chest, but not deep
chest, SSI might be due to common risk factors for super-
ficial infection.31 Mortality was significantly increased in
patients with deep chest SSIs in the year after CABG
surgery in comparison with that seen in uninfected control
subjects. Although our assessment of mortality beyond the
first month after the operation relied primarily on passive
reporting, the 22% mortality rate observed in our patients
with deep chest SSIs is consistent with that reported previ-
ously in other studies.11,32,33 Interestingly, we also found an
increased risk of 1-year mortality in patients with superficial
chest SSIs compared with that seen in uninfected control
subjects, attesting to the clinical importance of these out-
comes.
Association of Deep Chest SSI With Predicted
Mortality
Consistent with the lack of association between superficial
chest SSI and number of comorbidities and the results of the
multivariate analysis, we did not observe an association
between the predicted risk of mortality and the prevalence
of superficial chest SSI. The association between predicted
risk of mortality and deep chest SSI was equivocal and
depended on the categorization of the predicted risk. In
contrast, we have found that the prevalences of sepsis and
pneumonia in the month after CABG surgery are linearly
related to increasing predicted mortality.30 Hattler and col-
leagues34 have previously reported significantly increased
risks of mediastinitis and septicemia in patients with a 30%
predicted risk of mortality or higher compared with that
seen in patients with the lowest risk of mortality. This
difference might have been due to the small number of cases
during our study period. Clarification of this result will
likely require a multi-institutional analysis of a larger num-
ber of patients.
Increased Risk of Deep Chest SSI in Obese Diabetic
Patients
The increased risk of deep chest SSI in obese, but not in
nonobese, diabetic patients might be due to poor glucose
control. Increased risk of deep chest SSI after CABG sur-
gery has been demonstrated in diabetic patients with preop-
erative serum glucose levels exceeding 200 mg/dL.22 Dia-
betic patients with serum glucose levels of less than 200
mg/dL were not at increased risk. Furthermore, implemen-
tation of a strict glucose-control regimen has been shown to
reduce deep chest SSIs in diabetic patients to the baseline
rate for patients without diabetes.25,26 Unfortunately, we do
not have data on perioperative glucose levels for the study
patients; however, obese diabetic patients are more likely to
have high serum glucose levels than nonobese diabetic
patients.35
Transfusion as a Risk Factor for Deep Chest SSI
In both the stratified and multivariate analyses, nonobese
patients receiving large numbers of transfusions were at
increased risk of deep, but not superficial, chest SSI. This
increased risk might be attributed to immunosuppressive
effects of blood transfusion, the presence of a hematoma to
act as a culture medium for bacterial growth, or the possi-
bility that bleeding is indicative of compromised wound
closure. Receipt of blood products after CABG surgery has
previously been associated with prolonged hospital stay and
an increased incidence of sepsis and pneumonia.18,36 Other
investigators have suggested that white blood cells contam-
inating pRBC and platelet units might act as immunomodu-
lators.18 Interestingly, obese patients requiring transfusion
were not at increased risk of deep chest infection in this
study. This could be a statistical artifact given the small
number of obese patients with deep chest SSIs who required
multiple transfusions.
Additional Risk Factors for Deep and Superficial
Chest SSI
Active smoking was an independent risk factor for superfi-
cial chest SSI, possibly because of impaired cutaneous
circulation. Conversely, use of antiplatelet medication be-
fore the operation was associated with a decreased risk of
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superficial chest infections, but not deep chest infections,
possibly as a result of improved circulation. Neither of these
factors was associated with deep chest SSI. Placement of an
IABP during or after the operation was associated with an
increased risk of deep chest SSI, possibly reflecting a rela-
tionship between tissue perfusion and infection. Because the
number of patients in our study who required an IABP was
small (66 patients), this finding requires confirmation in
larger studies.
Analysis of Surgeon and Resident Rates of Infection
After Risk Adjustment
We used the results of our multivariate models to control for
independent risk factors in analyzing infection rates for
surgical staff. Several residents and staff surgeons had ad-
justed rates of superficial chest infections significantly
higher than those of their peers, which was not a surprising
finding given the large number of individual residents and
surgeons involved. What was of interest, however, was that
3 residents were found to have significantly higher rates of
both superficial and deep chest SSI than their peers. This
suggests that this type of risk-adjusted comparison could be
used on an ongoing basis for identification of surgical
practices associated with higher than expected rates of in-
fection and could be the basis for education and interven-
tion.
Study Limitations and Strengths
As in most previous reports, the principle limitation of this
study is the small numbers of superficial and deep chest
SSIs. Resolution of this will likely require a multi-institu-
tional approach because of the low prevalence of these
infections in most centers. Despite this, the numbers of
superficial and deep SSIs in this study are still larger than
those in most other published reports. Furthermore, our
study benefits from the rigor of the data set, with confirma-
tion of SSI by using National Nosocomial Infections Sur-
veillance criteria to verify the identification of deep and
superficial infections. The STS database includes a large
quantity of information on potential risk factors, although
admittedly some potential predictor variables are not avail-
able, such as oxygen saturation. Our database does, how-
ever, include information concerning the number of units of
transfused blood products, duration of antibiotic prophy-
laxis, and other data added at the request of our infection-
control program. Because our database included informa-
tion on a variety of other infectious outcomes, we were also
able to exclude patients with other infections as control
subjects.
Our multivariate analysis of risk factors for deep and
superficial chest SSIs included all potentially relevant
2-way interaction factors. We were interested in the inter-
action of obesity and other factors in this patient population
to determine whether there are unique groups of patients
undergoing CABG who are at increased risk of infection
because of their combination of different risk factors. We
identified obese diabetic and nonobese individuals with
excessive bleeding postoperatively as being at higher risk of
deep chest infections. There was no interaction between
diabetes and receipt of bilateral ITA grafts because the
number of patients who received bilateral ITA grafts during
the interval of this study was very small. To our knowledge,
only 2 previous studies22,37 have included an analysis of
interactions between variables to determine whether partic-
ular subsets of patients are at increased risk of infection,
although only one of these studies analyzed specifically the
risk of deep chest SSI.22
The major strength of this study was the construction of
separate models to discriminate between risk factors for
deep versus superficial chest SSI. Of the many previous
studies of chest wound infections in patients undergoing
CABG, most have analyzed risk factors for superficial and
deep chest SSIs together (ie, reported risks for chest infec-
tions2,3,5,7,14) or have analyzed deep chest infections or
mediastinitis only.6,11,16,17,19,22 In addition, some studies
have pooled the analyses to include patients with any SSI,
obscuring the delineation of risk factors specific to chest or
harvest-site infections.9,12,13,15,37 Our analysis of deep and
superficial chest SSI separately has allowed for the discrim-
ination of risk factors unique to each infection, emphasizing
the difference in the 2 types of infection.
Relevance to Infection Control
The goal of this analysis was to use the knowledge of risk
factors to develop strategies to reduce the incidence of SSI
in patients undergoing CABG. The most obvious strategy to
reduce the incidence of deep chest SSI supported by the
findings of this study is the implementation of a diabetic
protocol25,26 to maintain adequate serum glucose levels in
obese diabetic patients. Another potential method to reduce
the risk of deep chest SSI is the use of antibiotic prophylaxis
in patients at increased risk because of transfusion with very
large amounts of blood products postoperatively. Prophy-
laxis of multiply transfused patients cannot be recom-
mended on the basis of this study alone because the time
after the operation that transfusions were given is not
known. A further method to reduce the risk of deep chest
SSI in multiply transfused patients involves the use of white
blood cell–depleted blood products, although it is not clear
from the results of randomized clinical trials that this re-
duces the risk of SSI.18 Development of interventions to
reduce the risk of superficial chest SSI are more difficult to
envision because the risk factors for these infections cannot
be directly modified by physicians or infection-control per-
sonnel. Clearly more work needs to be done in the area of
infection control to develop new interventions to reduce the
risk of SSI in patients undergoing CABG surgery.
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Summary
Deep chest SSI continues to be a serious complication of
CABG surgery, carrying with it the prospect of substantial
morbidity, increased mortality, and high costs. Superficial
chest SSI results in additional, albeit less profound, morbidity
and increased costs. We have demonstrated different independ-
ent risk factors for the 2 infections, suggesting different mech-
anisms of pathogenesis. We have also identified specific com-
binations of risk factors that place patients at particularly high
risk. These results further suggest that risk stratification can be
used to adjust rates of infection associated with individual
surgeons for the purpose of quality-improvement programs.
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